kyotorphin has been researched along with naloxonazine in 1 studies
| Studies (kyotorphin) | Trials (kyotorphin) | Recent Studies (post-2010) (kyotorphin) | Studies (naloxonazine) | Trials (naloxonazine) | Recent Studies (post-2010) (naloxonazine) |
|---|---|---|---|---|---|
| 168 | 0 | 22 | 200 | 0 | 30 |
| Protein | Taxonomy | kyotorphin (IC50) | naloxonazine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0072 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.136 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.085 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Browning, KN; Kalyuzhny, AE; Travagli, RA | 1 |
1 other study(ies) available for kyotorphin and naloxonazine
| Article | Year |
|---|---|
Opioid peptides inhibit excitatory but not inhibitory synaptic transmission in the rat dorsal motor nucleus of the vagus.
Topics: Animals; Brain Stem; Digestive System; Electric Stimulation; Endorphins; Excitatory Postsynaptic Potentials; Immunohistochemistry; In Vitro Techniques; Motor Neurons; Naloxone; Narcotic Antagonists; Neural Inhibition; Opioid Peptides; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Receptors, Opioid, mu; Solitary Nucleus; Synaptic Transmission; Vagus Nerve | 2002 |